Clinical Trial

Comparison of FNB to EUS-CNB for Pancreatic Lesions

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of this study is to compare the tissue specimen quality and diagnostic accuracy of biopsies obtained with one puncture of a regular 22 FNB G needle and the motorized EUS CNB device of pancreatic lesions. The secondary aims are to compare the rate of blood contamination in the specimens obtained from biopsies of pancreatic lesions and the overall procedure duration. The hypothesis of this study is that the proportion of cases in which a single puncture of the lesion in question delivers adequate diagnostic tissue is higher with the motorized EUS CNB than with the 22 G FNB.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-01 -> 2026-11-01 2026-05-29
minor Completion pushed: 2026-06-01 -> 2026-11-01 2026-05-29
Trial Details
NCT Number NCT07240818
Lead Sponsor University of California, Davis
Conditions Diagnosis of a Pancreaticobiliary Disorder, Biopsy, EUS Guided Biopsy
Enrollment 30 participants
Start Date 2026-07-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04